Does cannabis hold the key to treating cardiometabolic disease?

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 3, 2006, Pages 116-117

  Szmitko, Paul E ^a   Verma, Subodh ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DRONABINOL; ENDOCANNABINOID; RIMONABANT;

ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG MECHANISM; DYSLIPIDEMIA; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INSULIN RESISTANCE; LOW CALORY DIET; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TREATMENT OUTCOME; VASCULITIS;

CANNABIS; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 33644593422     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0504     Document Type: Review

References (9)

1. Steffens S et al. (2005) Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434: 782-786
2. Van Gaal LF et al. (2005) Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365: 1389-1397
3. Di Marzo V et al. (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3: 771-784
4. 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305
5. Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5: 400-411
6. Roth MD (2005) Pharmacology: Marijuana and your heart. Nature 434: 708-709
7. Lau DCW et al. (2005) Adipokines: Molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288: 2031-2041
8. Batkai S et al. (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110: 1996-2002
9. Le Foll B et al. (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15: 2139-2143